Page last updated: 2024-08-16

resveratrol and dihydrotestosterone

resveratrol has been researched along with dihydrotestosterone in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (85.71)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Kai, L; Levenson, AS1
Erbas, O; Ergenoglu, M; Karadadas, N; Taskiran, D; Yavasoglu, A; Yeniel, O; Yildirim, AG; Yildirim, N1
Cohen, AS; Hougaard, DM; Jørgensen, JO; Kjaer, TN; Neghabat, S; Ornstrup, MJ; Pedersen, SB; Poulsen, MM; Richelsen, B1
Chang, TC; Changou, CA; Chin, YT; Davis, PJ; Fu, E; HuangFu, WC; Lai, HY; Lin, HY; Liu, LF; Yang, SH1
Kaplan, SA1
Choi, KC; Go, RE; Hwang, KA; Jang, YG1
Chen, YR; Davis, PJ; Ho, Y; Li, ZL; Lin, HY; Shih, YJ; Wang, K; Whang-Peng, J1

Reviews

1 review(s) available for resveratrol and dihydrotestosterone

ArticleYear
Integrin αvβ3 in the Mediating Effects of Dihydrotestosterone and Resveratrol on Breast Cancer Cell Proliferation.
    International journal of molecular sciences, 2020, Apr-21, Volume: 21, Issue:8

    Topics: Androgens; Animals; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dihydrotestosterone; Humans; Integrin alphaVbeta3; Protein Binding; Receptors, Androgen; Resveratrol; Signal Transduction

2020

Trials

1 trial(s) available for resveratrol and dihydrotestosterone

ArticleYear
Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men.
    The Prostate, 2015, Volume: 75, Issue:12

    Topics: Aged; Androgens; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Dihydrotestosterone; Double-Blind Method; Humans; Male; Metabolic Syndrome; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Regression Analysis; Resveratrol; Stilbenes; Testosterone; Testosterone Congeners

2015

Other Studies

5 other study(ies) available for resveratrol and dihydrotestosterone

ArticleYear
Combination of resveratrol and antiandrogen flutamide has synergistic effect on androgen receptor inhibition in prostate cancer cells.
    Anticancer research, 2011, Volume: 31, Issue:10

    Topics: Androgen Antagonists; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cycloheximide; Dihydrotestosterone; Down-Regulation; Drug Synergism; Flutamide; Gene Expression Regulation, Neoplastic; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Protein Processing, Post-Translational; Receptors, Androgen; Resveratrol; RNA, Messenger; Stilbenes; Transcriptional Activation

2011
Effects of Resveratrol on Ovarian Morphology, Plasma Anti-Mullerian Hormone, IGF-1 Levels, and Oxidative Stress Parameters in a Rat Model of Polycystic Ovary Syndrome.
    Reproductive sciences (Thousand Oaks, Calif.), 2015, Volume: 22, Issue:8

    Topics: Animals; Anti-Mullerian Hormone; Antioxidants; Biomarkers; Dihydrotestosterone; Disease Models, Animal; Female; Glutathione Peroxidase; Insulin-Like Growth Factor I; Ovarian Follicle; Ovary; Oxidative Stress; Polycystic Ovary Syndrome; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Superoxide Dismutase

2015
Mechanisms of dihydrotestosterone action on resveratrol-induced anti-proliferation in breast cancer cells with different ERα status.
    Oncotarget, 2015, Nov-03, Volume: 6, Issue:34

    Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dihydrotestosterone; Drug Interactions; Estrogen Receptor alpha; Female; Humans; Integrin alphaVbeta3; MCF-7 Cells; Phosphorylation; Resveratrol; Signal Transduction; Stilbenes

2015
Re: Resveratrol Reduces the Levels of Circulating Androgen Precursors but has No Effect on Testosterone, Dihydrotestosterone, PSA Levels or Prostate Volume. A 4-Month Randomised Trial in Middle-Aged Men.
    The Journal of urology, 2016, Volume: 195, Issue:6

    Topics: Androgens; Dihydrotestosterone; Humans; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Resveratrol; Stilbenes; Testosterone

2016
Resveratrol inhibits DHT-induced progression of prostate cancer cell line through interfering with the AR and CXCR4 pathway.
    The Journal of steroid biochemistry and molecular biology, 2019, Volume: 192

    Topics: Androgen Receptor Antagonists; Androgens; Antioxidants; Apoptosis; Cell Movement; Cell Proliferation; Dihydrotestosterone; Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Male; Prostatic Neoplasms; Receptors, Androgen; Receptors, CXCR4; Resveratrol; Signal Transduction; Tumor Cells, Cultured

2019